Presentations

210 Results
Madison Ford
Recognizing And Addressing a Global Patient Enrollment Crisis
Outsourcing Clinical Trials, New England
Boston, MA
Ken Getz
The Changing Global Drug Development Landscape
Outsourcing Clinical Trials, New England
Boston, MA
Mary Jo Lamberti
New Benchmarks on Clinical Trial Sourcing Models and their Association with Trial Performance
Outsourcing Clinical Trials, New England
Boston, MA
Ken Getz, Mary Jo Lamberti, Jennifer Kim
Tufts CSDD's 50 Years of Impact Breakfast Roundtables
Outsourcing Clinical Trials, New England
Boston, MA
Abigail Dirks
New Insights, Strategies and Practices to Optimize Protocol Data Collection
DIA Japan
Tokyo, Japan
Ken Getz
Optimizing site partnering and engagement
Scope Summit Europe
Barcelona, Spain
Zak Smith
Improving Site Activation and Patient Enrollment Performance
Scope Summit Europe
Barcelona, Spain
Zak Smith
New Benchmarks on Clinical-Trial Sourcing Models and Their Association with Trial Performance
Scope Summit Europe
Barcelona, Spain
Ken Getz
RBQM at a Turning Point: from Adoption to Operational Maturity
RBQM Live!
Virtual
Ken Getz
Accelerating Clinical Development through Earlier Insights: What the Data Tells Us
IQVIA Webinar
Virtual
Ken Getz
Insights and Opportunities to Selectively Streamline Protocol Data Collection
FDA Town Hall
Virtual
Ken Getz, Mary Jo Lamberti, Jennifer Kim
Special TCSDD Breakfast Session for Early Risers
DPHARM
Boston, MA
Ken Getz
Keynote: Change Management: Why Innovation Adoption Takes Years
DPHARM
Boston, MA
Ken Getz
Fireside Chat: Navigating Next Generation Clinical Development
DPHARM
Boston, MA
Mary Jo Lamberti, Maria Florez
Funding and Perspectives on DCT Solutions: Recent Data from Tufts CSDD
Clinical Trials in Oncology East Coast Conference
Boston, MA
Zak Smith
Site Investment and Experience with DCT Solutions
Investigator Trials Conference
Lisbon, Portugal
Ken Getz
Optimizing Protocol Data Collection to Reduce Site and Participant Burden
DIA Annual Meeting
Philadelphia, PA
Abigail Dirks
Case Studies on AI-Enabled and Analytical Practices and Solutions Reducing Site and Participant Burden in Clinical Trials
DIA Annual Meeting
Philadelphia, PA
Jennifer Kim
Leading for Growth: Unlocking Individual Potential in Your Team
DIA Annual Meeting
Philadelphia, PA
Ken Getz
Evidence-Based Insights Informing Participant Compensation Strategies
DIA Annual Meeting
Philadelphia, PA
Ken Getz
New Data on Patient Perceptions and Experiences Finding and Participating in Clinical Trials
DIA Annual Meeting
Philadelphia, PA
Ken Getz
AI-Enabled Patient Voice Integration in Digital Protocol Design
SCOPE X
Boston, MA
Ken Getz
Empowering Continuous Improvement: New Strategies to Manage Protocol Complexity
DIA China
Shanghai, China
Ken Getz
New strategies to drive clinical research efficiency
OCT EU
Barcelona, Spain
Ken Getz
Cost drivers, sustainability and future directions research recruitment
National Institute on Aging (NIH)
Virtual
Mary Jo Lamberti, Maria Florez
Advancing Clinical Development Through Direct-to-Patient Models and Artificial Intelligence
Clinical Trial Supply New England
Boston, MA
Ken Getz
State of the Drug Development Operating Environment
Chief Medical Officers Summit
Boston, MA
Ken Getz
New insights and strategies to reduce participant burden by optimizing clinical trial data collection
Patients as Partners
Boston, MA
Hana Do
Assessing the Transition from Legacy, On-Site Monitoring to Centralized and Risk-Based Monitoring
Festival of Biologics USA 2026
San Diego, CA
Ken Getz
Use Cases of AI/Generative and Agentic AI in Drug Development
SCOPE US Summit 2026
Orlando, FL
Mary Jo Lamberti
DIA Survey Results on the Adoption of AI in Drug Development
Deming Conference on Applied Statistic
Atlantic City, NJ
Joseph DiMasi
Accelerate with Confidence: Research-based Insights to guide CDMO-CRO Partnership Decisions
Patheon ThermaFisher Scientific
Virtual
Ken Getz
Unpacking the drivers of drug development costs
SyncUp Summit
Chatham, Ma
Mary Jo Lamberti, Maria Florez
AI and ML Use Cases
OCT New England
Boston, MA
Ken Getz
Optimizing protocol data collection to reduce site and patient participation burden
SCOPE Europe
Barcelona, Spain
Ken Getz
AI in clinical trials: Where science meets systems
Scope Europe
Barcelona, Spain
Ken Getz
Monitoring a Changing Investigative Site Landscape
Site Solutions Summit
Orlando, FL
Abigail Dirks, Ken Getz
Quantifying the ROI of Implementing RBQM Components
RBQMLive!
Virtual
Mary Jo Lamberti, Maria Florez
Applying AI and New Methodologies
2025 IQVIA Institute Research Forum |
Boston, MA
Hana Do
Characterizing How Sponsors are Transitioning from Onsite to Centralized and Risk-Based Monitoring Approaches
Contract Pharma
New Brunswick, NJ
Ken Getz
New insights on optimizing the collection of protocol data
DPharm
Philadelphia, Pa
Hana Do
Characterizing the Transition From Legacy, On-Site to Centralized and Risk-Based Monitoring
Clinical Trials in Oncology
Boston, MA
Jennifer Kim (Chair), Madison Ford (Panelist)
Leader Effectiveness: Inclusive Leadership Practices to Improve Employee Engagement and Performance.
DIA Global 2025
Washington DC
Jennifer Kim (Chair)
Panel: Examining Bias in Lung Cancer Study Protocols: Lessons Learned
DIA Global 2025
Washington DC
Joan Chambers (Panelist)
Panel: Patient Referrals: Is It Hope or Hype?
DIA Global 2025
Washington, DC
Ken Getz
Updated Tufts Center for the Study of Drug Development Benchmarks on Vendor Qualification Practices: Insights from the Evolving Pharma Landscape
DIA Global 2025
Washington DC
Mary Jo Lamberti
The Adoption of Artificial Intelligence & Machine Learning in Clinical Research
DIA Global 2025
Washington DC
Patricia Davidson (Panelist)
Panel: Novel Framework and Case Study to Support Scientific Rigor: A New Community-Focused Model for Sustainable Clinical Trial Participation
DIA Global 2025
Washington, D.C.
Ken Getz
Charting the Path for Clinical Trials 2030
Clinical Trials Transformation Initiative - CTTI
Washington D.C.
Ken Getz
What Does the Future Hold for Clinical Development
Marcus Evans, Evolution Summit
Boston, MA